4142:TPE
Adimmune Corp
NT$ 17,30
arrow_upward
+0,58%(+0,100) 1D
23 jun, 09:00:15 GMT+8 · TWD
search
Alle symbolen
1D
5D
1M
6M
YTD
1J
5J
MAX
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor 4142 genereren…
Openen
NT$ 17,35
Hoog
NT$ 17,35
Laag
NT$ 17,30
Beursw.
7,43 mld.
Gem. vol.
1,28 mln.
Volume
15,00K
52 wk hoog
NT$ 22,50
52 wk laag
NT$ 15,90
WPA
NT$ -0,48
Uitstaande aandelen
235,29 mln.
Aantal medewerkers
564
Openen
NT$ 17,35
Hoog
NT$ 17,35
Laag
NT$ 17,30
Beursw.
7,43 mld.
Gem. vol.
1,28 mln.
Volume
15,00K
52 wk hoog
NT$ 22,50
52 wk laag
NT$ 15,90
WPA
NT$ -0,48
Uitstaande aandelen
235,29 mln.
Aantal medewerkers
564
Nieuwsartikelen
Van bronnen op internet
WSJ
·
54 minuten geleden
NYSE Marketing Chief Brings Media Playbook to Wall Street
TechStock²
·
38 minuten geleden
Nasdaq slips in after-hours as AI stocks drop, Dow stays positive
Insider Monkey
·
22 minuten geleden
10 Stocks Paying Off Big Time
Bloomberg.com
·
2 uur geleden
Asian Stocks Set for Gains as Oil Holds Losses: Markets Wrap
Profiel
Adimmune Corporation is a Taiwanese biopharmaceutical company headquartered in Taichung. Originally founded in 1965 as Taiwan’s first vaccine laboratory, it later evolved into a modern vaccine manufacturer and contract development and manufacturing organization. The company is notable for being the only influenza vaccine manufacturer in Asia certified by both the European Union Good Manufacturing Practice and the U.S. Food and Drug Administration, and the*only human vaccine manufacturer in Taiwan operating under PIC/S GMP standards. Wikipedia
Over Adimmune Corp
AI-content kan fouten bevatten. Meer informatie